Clinical Trial Update: Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update in Chinese patients with alveolar soft part sarcoma (GB226).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma

Drugs mentioned

• GB226

Snippet

Sponsor: Genor Biopharma Co., Ltd. | Conditions: Alveolar Soft Part Sarcoma | Phase 2 | Status: UNKNOWN